During the period 2000-2003, the Drug Analysis and Research Unit received and analyzed 33 samples of antiretroviral drugs. Locally manufactured products accounted for 57.6% of the samples, while the imported drugs constituted 42.4%. The drugs consisted of single, double and triple component preparations. They were subjected to identity, assay and dissolution tests. 30 samples (90.9%) complied with compendial specifications for these tests, while 3 failed. The results obtained show that the manufacture of quality generic antiretroviral drugs is achievable.